NASDAQ: MBRX
Moleculin Biotech Inc Stock Ownership - Who owns Moleculin Biotech?

Insider buying vs selling

Have Moleculin Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Walter V. KlempCEO;Pres2026-11-16141$7.41
$1.04kSell
Jonathan P. FosterCFO2026-11-1689$7.14
$635.46Sell
Jonathan P. FosterCFO2026-11-0410$8.46
$84.60Sell
Walter V. KlempCEO;Pres2026-11-0414$8.46
$118.44Sell
Donald H. PickerCSci2026-11-044$8.46
$33.84Sell
Jonathan P. FosterCFO2026-10-1530,485$0.37
$11.28kSell
Walter V. KlempCEO;Pres2026-10-1548,659$0.37
$18.00kSell
Walter V. KlempCEO and President2026-06-2288$3.12
$274.56Sell
Jonathan P. FosterChief Financial Officer2026-06-2241$3.12
$127.92Sell
Donald H. PickerChief Science Officer2026-06-2221$3.12
$65.52Sell

1 of 2

MBRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MBRX insiders and whales buy or sell their stock.

MBRX Shareholders

What type of owners hold Moleculin Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Waldemar Priebe343.43%3,645,573$28.22MInsider
Walter V. Klemp104.71%1,111,545$8.60MInsider
Donald H. Picker52.82%560,718$4.34MInsider
Jonathan P. Foster1.93%20,506$158.72kInsider
Robert E. George1.38%14,660$113.47kInsider
Jacqueline Northcut0.09%1,000$7.74kInsider
Jane Street Group LLC0.01%142$1.10kInstitution
Vanguard Fiduciary Trust Co0.01%108$835.92Institution
Geode Capital Management LLC0.01%104$804.96Institution
Hrt Financial LP0.01%60$464.40Institution

1 of 3

MBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MBRX0.01%99.99%Net SellingNet Selling
INAB0.02%99.98%Net Buying
INTS0.03%3.87%Net Buying
PTN0.00%100.00%Net Selling
MTRI0.05%99.95%Net BuyingNet Buying

Moleculin Biotech Stock Ownership FAQ

Who owns Moleculin Biotech?

Moleculin Biotech (NASDAQ: MBRX) is owned by 0.06% institutional shareholders, 504.37% Moleculin Biotech insiders, and 0.00% retail investors. Waldemar Priebe is the largest individual Moleculin Biotech shareholder, owning 3.65M shares representing 343.43% of the company. Waldemar Priebe's Moleculin Biotech shares are currently valued at $28.22M.

If you're new to stock investing, here's how to buy Moleculin Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.